Prescribing Provider Survey for the Texas Prescription Monitoring Program Due May 11, 2026
AI Summary
The Texas Health and Human Services Commission requires all Texas Medicaid-enrolled prescribing providers to complete a survey about their use of the Texas Prescription Drug Monitoring Program (PDMP) for controlled substance prescriptions. This survey covers prescription data from federal fiscal year 2025 and must be completed by May 11, 2026.
Action Required
By May 11, 2026: All prescribing providers enrolled in Texas Medicaid must complete the HHSC provider survey regarding Texas PDMP usage for controlled substance prescriptions covering federal fiscal year 2025 (October 1, 2024 to September 30, 2025). Contact vdp-advisory@hhs.texas.gov with questions. Failure to complete may affect ability to prescribe controlled substances for Medicaid patients.
Plan Types
Medicaid
States
TX
Specialties
family-medicine, internal-medicine, general-practice, pediatrics, ortho, general-surgery, neurosurgery, plastic-surgery, oral-maxillofacial-surgery, ophthalmology, ent, urology, ob-gyn, cardiology, neurology, gastroenterology, pulmonology, endocrinology, nephrology, rheumatology, oncology, hematology, infectious-disease, dermatology, emergency-medicine, critical-care, hospitalist, anesthesiology, pm-r, pain-management, sports-medicine, psychiatry